TB / MDR TB Project

TB / MDR TB Project

International Hospital Federation (IHF)

The Lilly MDR-TB Partnership was created in 2003 to combat multidrug-resistant tuberculosis (MDR-TB). The International Hospital Federation has been a member of the project since 2004.

The IHF bilateral partnership was created in 2004 upon recognition of the need, firstly, to address TB management/treatment from the perspective of the hospital/healthcare setting.

Secondly, and even more importantly, upon acknowledgment that 'ignorance' and exclusion of IHF membership group, may have led and can lead to adoption and implementation of contra-productive decisions and actions in the fight against MDR-TB.

Lundi, 23 Mars 2015 20:21

'Leading Lights' : Selection for March 2015

As we commemorate World TB Day, the ICN TB/MDR-TB Project would like to highlight our ‘Leading Lights’ initiative, which aims to showcase the work of exceptional nurses trained by the ICN TB/MDR-TB project who have made an outstanding contribution to TB prevention, care and management in their local facility and/or community. I am delighted to announce that we have selected five nurses (two from China, one from South Africa and two from Russia) as Leading Lights for this quarter, namely :

  • Wang Xiuhua  (from China)
  • Li Chunmei  (from China)
  • Ntombasekhaya Mlandu  (from South Africa)
  • Nadezhda Baycharova  (from Russia)
  • Ekaterina Ryabova   (from Russia)

Please click on the link below to find the information about these wonderful nurses and their contribution to the fight against TB.

Newsletter on March 2015 Leading Lights

International Union Against Tuberculosis and Lung Disease (UNION)

Despite recent progress, tuberculosis (TB) remains an important global public health problem. One-third of the world's population is currently infected with the tubercle bacillus that causes TB; and, according to the World Health Organization (WHO), there were 9.4 million new cases and 1.7 million deaths from TB in 2009.

Although TB is curable, inadequate TB control is one of the factors that has led to an increase in multidrug-resistant tuberculosis (MDR-TB), a particularly dangerous form of the disease, which is potentially incurable in many settings. MDR-TB is defined as disease caused by TB bacilli resistant to at least isoniazid and rifampicin, the two most powerful anti-TB drugs. Rates of MDR-TB are high in some countries and, coupled with the devastating effects of TB/HIV co-infection, threaten to undermine TB control efforts worldwide.

The Union has been a leader in tuberculosis prevention, control and treatment since it was founded in 1920 as the International Union Against Tuberculosis. It is mostly widely known for the research that led to the directly observed treatment, short course (DOTS) strategy, endorsed by the WHO and used to treat more than 37 million TB patients around the world.

Jeudi, 04 Décembre 2014 15:03

Update about the ICN TB Project

Nomination form "Leading Lights"

Nomination form

“Leading Lights” initiative for ICN TB Project

The “Leading Lights” award recognises outstanding contribution to the care of people affected by TB.

Eligibility: the nominee must be nurse or health care worker who

  • Is directly involved with caring for those affected by TB
  • Has received training as part of the ICN TB Project since 2005 either during a full TB workshop or from someone who has been trained by the project to train others

Who can nominate someone as a ‘Leading Light’?

  •  An individual can nominate themselves but has to provide the contact details of someone who can verify the information provided
  • Anyone can nominate another person who meets the criteria


only JPG,GIF or PNG format accepted

Reason for nomination or details of Performance

Please describe the special aspect of your/the nominee’s work you wish to highlight (max 500words)

A suggestion of the format of this description would be :

  1. The issue you/he/she wanted to tackle and why – what was the problem?
  2. What did you/he/she decide to do?
  3. How did you/he/she do it and who else was involved?
  4. Which ICN tools or materials did you/he/she find most helpful?
  5. What was the result of your/her/his efforts?
  6. How you feel things improved for yourself/the nominee, your/his/her colleagues and most importantly for patients?

Activities since training can also include : other people trained, impact on patient and/or project outcomes, changes made to practice, changes made to the environment, challenges faced, things that helped.

Any numbers are welcome.

If nominating yourself give the name and contact details of a referee.

New Jersey Medical School Global Tuberculosis Institute (Global TB Institute)

The New Jersey Medical School Global Tuberculosis Institute at Rutgers, The State University of New Jersey is a force in the effort to conquer and cure tuberculosis worldwide. The Institute plays a leading role in the international arena, providing expertise in program development, education and training and research to ministers of health, national TB programs and healthcare providers around the globe.

The Institute's work has no borders. Battling TB on the front lines, it has a proven track record in building the political will and international cooperation needed to relegate this disease to the history books, where it belongs.

Page 4 sur 20